Cystic fibrosis (CF) is a genetic disease primarily affecting the lungs and digestive system, but its impact extends to other organs, including the liver. Recent advancements in treatment, particularly with the drug combination elexacaftor-tezacaftor-ivacaftor (ETI), have dramatically improved lung function and growth for many individuals with CF. Now, research is focusing on whether these benefits … Read more
A latest strategy utilizing lipid nanoparticles (LNPs) to generate immune cells capable of fighting solid tumors in vivo – within the body – is demonstrating encouraging results in preclinical studies. The approach, detailed in recent research, bypasses many of the logistical hurdles and limitations associated with traditional chimeric antigen receptor (CAR) T-cell therapies, offering a … Read more
Recent advancements in the treatment of acute myeloid leukemia (AML) have prompted significant interest in the use of cord blood transplantation as a therapeutic option. A study examining the outcomes of initial cord blood transplantation utilizing FM80TBI as a conditioning regimen highlights its potential effectiveness in managing this aggressive form of cancer. Acute myeloid leukemia … Read more
The pursuit of peak performance is relentless in professional cycling, and increasingly, riders are turning to supplements to gain an edge. But with a vast and often confusing market, understanding which supplements are backed by solid science – and which are simply hype – is crucial. A recent review of the literature, published up to … Read more